{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-148566","form_type":"8-K","ticker":"DERM","cik":"0001867066","company_name":"Journey Medical Corp","filed_at":"2021-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.893761+00:00","generated_at":"2026-06-28T02:11:25.887512+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Journey Medical Q3 2021 net revenue $19.6M (+108% YoY); non-GAAP net income $3.5M","bullets":["Net revenue $19.6M vs $9.4M in Q3 2020, up 108%.","Non-GAAP net income $3.5M ($0.38 basic EPS) vs $0.6M in Q3 2020.","Completed November IPO: 3.52M shares at $10, net proceeds $31.2M.","New CFO appointed; DFD-29 Phase 3 first dosing expected Q1 2022.","Cash and equivalents $21.7M as of Sep 30, 2021, up from $8.2M at Dec 31, 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-148566","json":"https://secwatch.observer/filing/0001104659-21-148566.json","markdown":"https://secwatch.observer/filing/0001104659-21-148566.md","text":"https://secwatch.observer/filing/0001104659-21-148566.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867066/000110465921148566/0001104659-21-148566-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867066/000110465921148566/tm2135030d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T02:11:25.887512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}